Zobrazeno 1 - 10
of 18
pro vyhledávání: '"E V, Chumachok"'
Autor:
S V Nedogoda, V O Smirnova, V Yu Khripaeva, R V Palashkin, A A Ledyaeva, E V Chumachok, A S Salasyuk
Publikováno v:
Системные гипертензии, Vol 13, Iss 1, Pp 30-33 (2016)
Aim. To assess the possibility of monotherapy with perindopril after transferring from combination therapy with losartan and hydrochlorothiazide with respect to correction of the anthropometric, metabolic parameters, premature vascular aging and vasc
Externí odkaz:
https://doaj.org/article/a45b2cdc6c3e41b28c5037ba64b1466d
ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM
Autor:
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 9, Iss 1, Pp 25-30 (2015)
Aim. To assess the effect of meldonium (in combination with antihypertensive therapy) on the severity of asthenic syndrome (AS) in elderly patients with arterial hypertension (HT).Material and methods. Patients (n=180, >65 years old) with HT (grade 1
Externí odkaz:
https://doaj.org/article/035d636c7b0441f7ac95ab7381a3a0e2
Publikováno v:
Системные гипертензии, Vol 9, Iss 4, Pp 16-21 (2012)
Aim: to evaluate the ability of the angiotensin II receptor blocker losartan (Lorista, KPKA) to reduce the level of uric acid and to correct the parameters of vascular wall elasticity in patients with arterial hypertension, hyperuricemia, and gout. S
Externí odkaz:
https://doaj.org/article/7ffab57bbd7442b8a18f05a3a6e3af6f
Publikováno v:
Системные гипертензии, Vol 9, Iss 1, Pp 33-39 (2012)
Externí odkaz:
https://doaj.org/article/90f10c21d79047829afbe722d0d02ba4
Vozmozhnosti korrektsii giperurikemii lozartanom u patsientov s arterial'noy gipertenziey i podagroy
Publikováno v:
Системные гипертензии, Vol 8, Iss 4, Pp 64-68 (2011)
Externí odkaz:
https://doaj.org/article/e5226be6f06f4796a938b7cf3d16302e
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 10, Iss 6, Pp 24-29 (2011)
Aim. To assess the potential of the angiotensin II receptor antagonist losartan for the correction of hyperuricemia (HU) in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods. This open, randomised, controlled
Externí odkaz:
https://doaj.org/article/b72e643365c04007adfe06c5fb3351bb
Autor:
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, E. V. Chumachok, A. A. Ledyaeva, V. V. Tsoma
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 91-95 (2011)
The study aimed to assess the effects of long-term and course mildronate therapy (500 mg/d) on cognitive function in elderly patients with arterial hypertension (AH) and cognitive dysfunction. This open, randomised, controlled comparative study in pa
Externí odkaz:
https://doaj.org/article/065e89bf9ea74618b133945ef9e2826b
Autor:
E V Chumachok, V Yu Khripaeva, R V Palashkin, A A Ledyaeva, V. O. Smirnova, S. V. Nedogoda, A. S. Salasyuk
Publikováno v:
Russian Heart Journal. 15:192-196
Autor:
E V Chumachok, V. O. Smirnova, V Yu Khripaeva, A A Ledyaeva, R V Palashkin, A. S. Salasyuk, S. V. Nedogoda
Publikováno v:
Системные гипертензии, Vol 13, Iss 1, Pp 30-33 (2016)
Aim. To assess the possibility of monotherapy with perindopril after transferring from combination therapy with losartan and hydrochlorothiazide with respect to correction of the anthropometric, metabolic parameters, premature vascular aging and vasc
ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM
Autor:
E V Chumachok, S. V. Turkina, A A Ledyaeva, V. V. Tsoma, S. V. Nedogoda, I. A. Tyshchenko, L. V. Poletaeva, M. E. Statsenko
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 9, Iss 1, Pp 25-30 (2015)
Scopus-Elsevier
Scopus-Elsevier
Aim. To assess the effect of meldonium (in combination with antihypertensive therapy) on the severity of asthenic syndrome (AS) in elderly patients with arterial hypertension (HT).Material and methods. Patients (n=180, >65 years old) with HT (grade 1